Your browser doesn't support javascript.
loading
CD40 Agonist Restores the Antitumor Efficacy of Anti-PD1 Therapy in Muscle-Invasive Bladder Cancer in an IFN I/II-Mediated Manner.
Leblond, Marine M; Tillé, Laure; Nassiri, Sina; Gilfillan, Connie B; Imbratta, Claire; Schmittnaegel, Martina; Ries, Carola H; Speiser, Daniel E; Verdeil, Grégory.
Afiliação
  • Leblond MM; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
  • Tillé L; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
  • Nassiri S; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
  • Gilfillan CB; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Imbratta C; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
  • Schmittnaegel M; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
  • Ries CH; Roche Innovation Center Munich, Pharma Research and Early Development, Penzberg, Germany.
  • Speiser DE; Roche Innovation Center Munich, Pharma Research and Early Development, Penzberg, Germany.
  • Verdeil G; Department of Oncology, University of Lausanne, Lausanne, Switzerland.
Cancer Immunol Res ; 8(9): 1180-1192, 2020 09.
Article em En | MEDLINE | ID: mdl-32661095
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Antígenos CD40 / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Antígenos CD40 / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article